Benzyldihydroxyoctenone, a novel anticancer agent, induces apoptosis via mitochondrial-mediated pathway in androgen-sensitive LNCaP prostate cancer cells.

MLA

Moon, Hong Sang, et al. “Benzyldihydroxyoctenone, a Novel Anticancer Agent, Induces Apoptosis via Mitochondrial-Mediated Pathway in Androgen-Sensitive LNCaP Prostate Cancer Cells.” Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 3, Feb. 2009, pp. 742–44. EBSCOhost, https://doi.org/10.1016/j.bmcl.2008.12.029.

APA

Moon, H. S., Lim, H., Moon, S., Oh, H. L., Kim, Y.-T., Kim, M. K., & Lee, C.-H. (2009). Benzyldihydroxyoctenone, a novel anticancer agent, induces apoptosis via mitochondrial-mediated pathway in androgen-sensitive LNCaP prostate cancer cells. Bioorganic & Medicinal Chemistry Letters, 19(3), 742–744. https://doi.org/10.1016/j.bmcl.2008.12.029

Chicago

Moon, Hong Sang, Haeyoung Lim, Sangik Moon, Ha Lim Oh, Young-Tae Kim, Min Kyoung Kim, and Chul-Hoon Lee. 2009. “Benzyldihydroxyoctenone, a Novel Anticancer Agent, Induces Apoptosis via Mitochondrial-Mediated Pathway in Androgen-Sensitive LNCaP Prostate Cancer Cells.” Bioorganic & Medicinal Chemistry Letters 19 (3): 742–44. doi:10.1016/j.bmcl.2008.12.029.